Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Karuna Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues11.53.6
            Revenue growth219.0% 
Cost of goods sold14.54.8
Gross profit-3.0-1.2
            Gross margin-25.8%-32.9%
General and administrative3.01.2
EBIT-14.5-4.8
            EBIT margin-125.8%-132.9%
Pre-tax income-17.5-6.0
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-17.5-6.0
            Net margin-151.8%-166.8%
 
Diluted EPS($4,378,000.00) 
Shares outstanding (diluted)0.0 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy